Ausgabe Sonderheft 1/2000
Inhalt (18 Artikel)
Recombinant antibodies against ganglioside expressed on tumor cells
Nobuo Hanai, Kazuyasu Nakamura, Kenya Shitara
An immunotherapeutic approach to treatment of breast cancer: focus on trastuzumab plus paclitaxel
Teresa Gilewski, Andrew Seidman, Larry Norton, Clifford Hudis
Organ-specific expression of the intestinal epithelium-related antigen A33, a cell surface target for antibody-based imaging and treatment in gastrointestinal cancer
Junichi Sakamoto, Hiroshi Kojima, Junji Kato, H. Hamashima, H. Suzuki
Exploitation of the B cell repertoire for the identification of human tumor antigens
Michael Pfreundschuh
Immune recruitment by bispecific antibodies for the treatment of Hodgkin disease
Ligia da Costa, Christoph Renner, Frank Hartmann, Michael Pfreundschuh
SEREX analysis of gastric cancer antigens
Yuichi Obata, Toshitada Takahashi, Junichi Sakamoto, Hiromi Tamaki, Suketami Tominaga, Nobuyuki Hamajima, Yao-Tseng Chen, Lloyd J. Old
The critical role of Th1-dominant immunity in tumor immunology
Takashi Nishimura, Minoru Nakui, Marimo Sato, Kenji Iwakabe, Hidemitsu Kitamura, Masashi Sekimoto, Akio Ohta, Toshiaki Koda, Shinichiro Nishimura
Melanoma vaccines: the paradox of T cell activation without clinical response
Mai-Britt Nielsen, Francesco M. Marincola
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies
William G. Nelson, Jonathan W. Simons, Bahar Mikhak, Ju-Fay Chang, Angelo M. DeMarzo, Michael A. Carducci, Michael Kim, Christine E. Weber, Angelo A. Baccala, Marti A. Goeman, Shirley M. Clift, Dale G. Ando, Hyam I. Levitsky, Lawrence K. Cohen, Martin G. Sanda, Richard C. Mulligan, Alan W. Partin, H. Ballentine Carter, Steven Piantadosi, Fray F. Marshall
Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer
Kerry A. Chester, Astrid Mayer, Jeetendra Bhatia, Lynda Robson, Daniel I. R. Spencer, Stephen P. Cooke, Aiden A. Flynn, Surinder K. Sharma, Geoffery Boxer, R. Barbara Pedley, Richard H. J. Begent
Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells
Kenzaburo Tani, Yukoh Nakazaki, Hidenori Hase, Keisuke Takahashi, Miyuki Azuma, Junko Ohata, Reiko Kitamura, Fumihiko Komine, Maki Oiwa, Atsuko Masunaga, Taira Maekawa, Noriharu Satoh, Daiki Adachi, Yasushi Soda, Utako Machida, Muneomi Endo, Tomoko Yamazaki, Kiyoshi Watari, Arinobu Tojo, Naohide Yamashita, Shinji Tomikawa, Masazumi Eriguchi, Hirofumi Hamada, Yoshiaki Wakumoto, Kisaburo Hanazawa, Koh Okumura, Makoto Fujime, Taro Shuin, Kouji Kawai, Hideyuki Akaza, Shirley Clift, Dale Ando, Stephan Sherwin, Richard Mulligan, Shigetaka Asano
Human CD8 and CD4 T cell epitopes of epithelial cancer antigens
Noriyuki Sato, Yuki Nabeta, Hiroaki Kondo, Hiroeki Sahara, Yoshihiko Hirohashi, Kiyoteru Kashiwagi, Takayuki Kanaseki, Yuriko Sato, Shunshui Rong, Itaru Hirai, Kenjiro Kamiguchi, Yasuaki Tamura, Akihiro Matsuura, Shuji Takahashi, Toshihiko Torigoe, H. Ikeda
Development of a cancer vaccine: peptides, proteins, and DNA
Hiroshi Shiku, Lijie Wang, Yasushi Ikuta, Toshiharu Okugawa, Michael Schmitt, Xiaogang Gu, Kazunari Akiyoshi, Junzo Sunamoto, Hideo Nakamura